Location · Wilmington, DE
Clinical trials in Wilmington, DE
28 recruiting studies have a site in Wilmington, and 9 of them accept healthy volunteers.
28 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)
Prolaio
- Location
- Wilmington, DE + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)
Angitia Incorporated Limited
- Location
- Wilmington, DE + 5 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
AstraZeneca
- Location
- Wilmington, DE + 70 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
AstraZeneca
- Location
- Wilmington, DE + 53 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets
Trevi Therapeutics
- Location
- Wilmington, DE + 3 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Amgen
- Location
- Wilmington, DE + 136 other US sites
- Eligibility basics
- Ages 45–99
- RecruitingPhase 2/Phase 3
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
Merck Sharp & Dohme LLC
- Location
- Wilmington, DE + 7 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
GlaxoSmithKline
- Location
- Wilmington, DE + 36 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 2
A Study of TYRA-300 in Children With Achondroplasia: BEACH301
Tyra Biosciences, Inc
- Location
- Wilmington, DE + 11 other US sites
- Eligibility basics
- Ages 3–10
- RecruitingPhase 3
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Ascendis Pharma A/S
- Location
- Wilmington, DE + 21 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 4
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
CorMedix Therapeutics
- Location
- Wilmington, DE + 5 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Novo Nordisk A/S
- Location
- Wilmington, DE + 42 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Kaneka Medical America LLC
- Location
- Wilmington, DE + 9 other US sites
- Eligibility basics
- Up to age 21
- Recruiting
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
Kaneka Medical America LLC
- Location
- Wilmington, DE + 9 other US sites
- Eligibility basics
- Up to age 75
- RecruitingPhase 3
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Harmony Biosciences Management, Inc.
- Location
- Wilmington, DE + 18 other US sites
- Eligibility basics
- Ages 6+
- Recruiting
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Versono Medical Ltd
- Location
- Wilmington, DE + 5 other US sites
- Eligibility basics
- Ages 18–85
- Recruiting
A Study to Evaluate a New Semi-rigid Brace, the RESILIENT Brace by Thinks Works, as a Way to Limit Curve Worsening in Kids With Idiopathic Scoliosis.
Thinks Works, PBC
- Location
- Wilmington, DE
- Eligibility basics
- Ages 9–16
- RecruitingPhase 3
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic…
Takeda
- Location
- Wilmington, DE + 7 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 2
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Travere Therapeutics, Inc.
- Location
- Wilmington, DE + 16 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Wilmington, DE + 34 other US sites
- Eligibility basics
- Ages 12–18
- RecruitingHealthy volunteers
Non-Invasive Respiratory Monitor
Nemours Children's Clinic
- Location
- Wilmington, DE
- Eligibility basics
- Ages 11–17
- RecruitingHealthy volunteers
Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
National Alliance for Sickle Cell Centers
- Location
- Wilmington, DE + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Alliance for Clinical Trials in Oncology
- Location
- Wilmington, DE + 319 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Alliance for Clinical Trials in Oncology
- Location
- Wilmington, DE + 350 other US sites
- Eligibility basics
- Ages 18+